Video: The latest developments in life sciences IP litigation

A sneak preview for the third installment of our webinar series, “The future of life sciences in Canada”

Amid this year’s disruptions to IP litigation, we have seen high-impact developments affecting life sciences companies.

In our latest video, Andy Shaughnessy, Edward Fan, and Melanie Rowand give us a sneak peek of their upcoming webinar on October 29, exploring the latest developments affecting life sciences innovation and business models going forward, including:

  • the Federal Court of Canada, in a decision expected to have a big impact on inventions relating to medical diagnostic methods, recently declared the policy adopted by the patent office for determining subject matter eligibility of patent claims is improper; and
  • the impact of file wrapper estoppel being encoded into the Patent Act—will this change the approach to statements made during prosecution of a patent application?

Register for the upcoming webinar here and play the teaser video below for a preview of our upcoming conversation on data protection, patent term extension and strategies, and important decisions on substantive patent law.

To discuss these issues, please contact the author(s).

This publication is a general discussion of certain legal and related developments and should not be relied upon as legal advice. If you require legal advice, we would be pleased to discuss the issues in this publication with you, in the context of your particular circumstances.

For permission to republish this or any other publication, contact Janelle Weed.

© 2021 by Torys LLP.
All rights reserved.


Get in Touch